Prof Research published a new market report on the ophthalmic hospital market. It presents the largest 23 manufacturers in the ophthalmic hospital market. The report is a professional and in-depth study on the current state of the global ophthalmic hospital market with a focus on the Chinese market. The report provides key statistics on the market of the ophthalmic hospital. It is a valuable source of guidance and direction for companies and individuals interested in the ophthalmic hospital industry.

The global ophthalmic hospital market was valued to be 59,354 million USD in 2020. The ophthalmic hospital production value is anticipated to have grown with a CAGR of 5.84% in the coming years to reach 83,437 million USD in 2026.

AIER is the largest ophthalmic hospital in the world, it has a market share of 3.07% in value. AIER Eye Hospital Group is China's leading ophthalmology hospital group that covers Asia, Europe, and North America with huge scale and outstanding medical capacity. It has three listed companies in China (stock code: 300015) , Europe (Spain: CBAV), and Southeast Asia (Singapore: 40T) with a total number of 645 specialized eye hospitals and centers and the annual outpatient visits in mainland China exceeded 10 million. Among those eye hospitals and centers, there are 537 in Mainland China, 7 in Hong Kong, 1 in the United States, 88 in Europe, and 12 in Southeast Asia. AIER Eye Hospital Group acquired Clínica Baviera in 2017.

Beijing Tongren Hospital is the second-largest ophthalmic hospital in the world, it has a market share of 1.06% in value. Beijing Tongren Hospital is a famous institution that specializes in ophthalmology and otolaryngology (ear, nose and throat medicine). Its records state that it was established in 1886 by an American Methodist church.

FDEENT is the third-largest ophthalmic hospital in the world, it has a market share of 0.84% in value. The Eye, Ear, Nose and Throat Hospital affiliated to Fudan University, formerly the Shanghai Jewish Hospital, is a tertiary eye, ear, nose and throat specialist hospital integrating medical treatment, teaching and scientific research. The hospital was founded in 1952. It has eight clinical departments: ophthalmology, otorhinolaryngology, oculoplastic surgery, radiotherapy, anesthesiology, emergency medicine, stomatology and nursing, and five medical and technical departments: radiology, pathology, pharmacy, testing and nutrition. The hospital has three hospital areas, Fenyang, Baoqing and Pujiang, with unified management and homogenized services.

Massachusetts Eye and Ear is the fourth largest ophthalmic hospital in the world, it has a market share of 0.54% in value. Massachusetts Eye and Ear (Mass. Eye and Ear, or MEE) is a specialty hospital located in Boston, Massachusetts, United States, which focuses on ophthalmology (eye), otolaryngology (ear/nose/throat), and related medicine and research. Founded in 1824 as the Boston Eye Infirmary (BEI), it has also been known as the Massachusetts Charitable Eye and Ear Infirmary (MCEEI), and Massachusetts Eye and Ear Infirmary (MEEI). It is a teaching partner of Harvard Medical School.